Non-ILD related | ILD-related | ||||
---|---|---|---|---|---|
Hazard ratio | P-value | Hazard ratio | P-value | ||
Sex | Male | Reference | Reference | ||
Female | 0.97 | 0.0215 | 0.86 | <.0001 | |
Age (in years) | 1.01 | <.0001 | 1.02 | <.0001 | |
Entity | SARC | Reference | Reference | ||
IIP | 1.18 | <.0001 | 1.43 | <.0001 | |
OFI | 1.25 | <.0001 | 1.37 | <.0001 | |
DAI | 1.47 | <.0001 | 1.17 | 0.1034 | |
PNE | 1.07 | 0.0556 | 1.07 | 0.2349 | |
RAP | 1.57 | <.0001 | 1.39 | 0.0002 | |
EPP | 1.28 | <.0001 | 1.16 | 0.0073 | |
HSP | 1.15 | 0.0011 | 1.06 | 0.3537 | |
CTD | 1.91 | <.0001 | 1.02 | 0.7829 | |
OSAS | If present or occuring before event | 0.91 | <.0001 | 0.96 | 0.0165 |
Depression | If present or occuring before event | 0.95 | <.0001 | 0.97 | 0.0259 |
Diabetes | If present or occuring before event | 0.96 | <.0001 | 0.93 | <.0001 |
GERD | If present or occuring before event | 0.96 | <.0001 | 1.00 | 0.9959 |
COPD | If present or occuring before event | 0.98 | 0.1147 | 1.35 | <.0001 |
CHD | If present or occuring before event | 1.17 | <.0001 | 1.19 | <.0001 |
Lung cancer | If present or occuring before event | 0.79 | <.0001 | 0.95 | 0.0068 |
Pulmonary hypertension | If present or occuring before event | 0.97 | 0.0042 | 0.76 | <.0001 |
Number of comorbidities | 1.18 | <.0001 | 1.11 | <.0001 | |
Immunosuppressive drugs | Immediate onset | Reference | Reference | ||
Late onset | 1.27 | 0.0002 | 1.42 | <.0001 | |
Never | 0.98 | 0.5684 | 0.85 | 0.0002 | |
Anti-fibrotic drugs | Immediate onset | Reference | Reference | ||
Late onset | 0.92 | 0.4798 | 2.27 | <.0001 | |
Never | 1.07 | 0.226 | 1.03 | 0.7111 | |
Steroids | Immediate onset | Reference | Reference | ||
Late onset | 1.24 | <.0001 | 1.64 | <.0001 | |
Never | 0.91 | <.0001 | 0.71 | <.0001 |